PLX
Protalix BioTherapeutics (PLX)
$81
About Protalix BioTherapeutics (PLX)
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Details
Daily high
$1.83
Daily low
$1.74
Price at open
$1.74
52 Week High
$3.10
52 Week Low
$1.32
Market cap
145.6M
Dividend yield
0.00%
Volume
341,283
Avg. volume
500,149
P/E ratio
26.04
Protalix BioTherapeutics News
Details
Daily high
$1.83
Daily low
$1.74
Price at open
$1.74
52 Week High
$3.10
52 Week Low
$1.32
Market cap
145.6M
Dividend yield
0.00%
Volume
341,283
Avg. volume
500,149
P/E ratio
26.04